JMP SECURITIES HEALTHCARE CONFERENCE to BE HELD in NEW YORK Event to Take Place at the New York Palace Hotel on October 5 and 6, 2009

JMP SECURITIES HEALTHCARE CONFERENCE TO BE HELD IN NEW YORK Event to Take Place at The New York Palace Hotel on October 5 and 6, 2009

SAN FRANCISCO, Sept. 29, 2009 — JMP Group Inc. (NYSE: JMP), an investment banking and alternative asset management firm, announced today that JMP Securities will host the fourth annual JMP Securities Healthcare Focus Conference at The New York Palace hotel in New York on Monday and Tuesday, October 5 and 6, 2009.

The two-day conference will feature presentations to an audience of institutional investors and financial sponsors by senior executives of nearly 90 public and private companies representing the biotechnology, medical devices, healthcare services and healthcare information technology industries.

For additional details or to register to attend the event, visit www.jmpsecurities.com/about/events.html or contact your JMP Securities institutional sales representative.

Companies scheduled to present as of September 29, 2009:

ACADIA Pharmaceuticals Inc. Acceleron Pharma, Inc. Agendia Alexza Pharmaceuticals, Inc. Allos Therapeutics, Inc. Allscripts-Misys Healthcare Solutions, Inc. Alnylam Pharmaceuticals, Inc. American CareSource Holdings, Inc. Anadys Pharmaceuticals, Inc. Ardea Biosciences, Inc. athenahealth, Inc. AtriCure, Inc. AVEO Pharmaceuticals, Inc. AVI BioPharma, Inc. BG Medicine, Inc. BioCryst Pharmaceuticals, Inc. Brookdale Senior Living Inc. Cadence Pharmaceuticals, Inc. CardioDx, Inc. Cardiome Pharma Corp. Celera Corporation Celgene Corporation Chemed Corporation Clinical Data, Inc. CombinatoRx, Incorporated CONMED Corporation Corcept Therapeutics Incorporated Cyberonics, Inc. Cytokinetics, Incorporated

© 2009 JMP Group Inc. 1 DexCom, Inc. Dialysis Corporation of America Dyax Corp. Echo Therapeutics, Inc. Enanta Pharmaceuticals, Inc. Genomic Health, Inc. Given Imaging Ltd. GlobeImmune, Inc. Greatbatch, Inc. Healthways, Inc. Human Genome Sciences, Inc. Idenix Pharmaceuticals, Inc. ImmuPharma plc Impax Laboratories, Inc. Incyte Corporation InfuSystem Holdings, Inc. Insulet Corporation Integra LifeSciences Holdings Corporation InterMune, Inc. InTouch Technologies, Inc. Inverness Medical Innovations, Inc. Isis Pharmaceuticals, Inc. Kensey Nash Corporation LipoScience, Inc. LTC Properties, Inc. MannKind Corporation MedAssets, Inc. Myriad Genetics, Inc. NeurogesX, Inc. NuVasive, Inc. Odyssey HealthCare, Inc. Optimer Pharmaceuticals, Inc. Orexigen Therapeutics, Inc. Orthofix International N.V. Osiris Therapeutics, Inc. Pharmasset, Inc. Precision Therapeutics, Inc. PTC Therapeutics, Inc. Quality Systems, Inc. RadNet, Inc. Rockwell Medical Technologies, Inc. RTI Biologics, Inc. S*BIO Pte Ltd. Salix Pharmaceuticals, Ltd. Sangamo BioSciences, Inc. Savient Pharmaceuticals, Inc. Seattle Genetics, Inc. Silverado Senior Living, Inc. SXC Health Solutions Corp. Symmetry Medical Inc. TargeGen, Inc. Tethys Bioscience, Inc.

About JMP Group JMP Group Inc. is a full-service investment banking and alternative asset management firm that provides investment banking, sales and trading, and equity research services to corporate and institutional clients and alternative asset management products to institutional and high-net-worth investors. JMP Group operates through three subsidiaries: JMP Securities, JMP Credit Corporation and Harvest Capital Strategies. For more information, visit www.jmpg.com.

Investor Relations & Media Contact Andrew Palmer (415) 835-8978 [email protected]